Poonawalla Fincorp Limited – ESOP Grant Announcement (27 Mar 2026)

Key Highlights

• Date of approval: 27 Mar 2026
• Option grant: 1,000,000 stock options (Tranche‑39)
• Plan: Employee Stock Option Plan‑2024 – Scheme‑II
• Exercise price: Rs 387.95 per share
• Vesting: As per the ESOP‑2024 schedule (details in the plan document)
• Regulatory basis: SEBI Listing Regulations (Regulation 30) and SEBI Share‑Based Employee Benefits & Sweat Equity Regulations, 2021

Why This Matters

• Employee motivation & retention: Granting ESOPs aligns staff interests with shareholders, encouraging performance and reducing turnover.
• Potential dilution: Full exercise would increase the share count, modestly diluting existing holdings.
• Cash inflow on exercise: Exercising options at Rs 387.95 will bring fresh capital into the company.
• Compliance: The grant adheres to SEBI’s disclosure and governance requirements, reflecting sound corporate governance.

Investor Implications

• Risk: Dilution risk if a large portion of options are exercised.
• Opportunity: Strengthened employee incentives could translate into better operational performance and profitability over the medium term.
• Neutral immediate impact: No change to current earnings, cash flow, or balance sheet until options are exercised.

Outlook

Given the strategic intent behind the ESOP grant and the limited immediate financial impact, the outlook is moderately positive. The move supports long‑term value creation while keeping dilution manageable.

Prepared on 27 Mar 2026 for Poonawalla Fincorp investors.